Extracellular DNA Traps Released by Acute Promyelocytic Leukemia Cells Through Autophagy
Overview
General Medicine
Authors
Affiliations
Acute promyelocytic leukemia (APL) cells exhibit disrupted regulation of cell death and differentiation, and therefore the fate of these leukemic cells is unclear. Here, we provide the first evidence that a small percentage of APL cells undergo a novel cell death pathway by releasing extracellular DNA traps (ETs) in untreated patients. Both APL and NB4 cells stimulated with APL serum had nuclear budding of vesicles filled with chromatin that leaked to the extracellular space when nuclear and cell membranes ruptured. Using immunofluorescence, we found that NB4 cells undergoing ETosis extruded lattice-like structures with a DNA-histone backbone. During all-trans retinoic acid (ATRA)-induced cell differentiation, a subset of NB4 cells underwent ETosis at days 1 and 3 of treatment. The levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were significantly elevated at 3 days, and combined treatment with TNF-α and IL-6 stimulated NB4 cells to release ETs. Furthermore, inhibition of autophagy by pharmacological inhibitors or by small interfering RNA against Atg7 attenuated LC3 autophagy formation and significantly decreased ET generation. Our results identify a previously unrecognized mechanism for death in promyelocytes and suggest that ATRA may accelerate ET release through increased cytokines and autophagosome formation. Targeting this cellular death pathway in addition to conventional chemotherapy may provide new therapeutic modalities for APL.
The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases.
Zeng L, Xiang W, Xiao W, Wu Y, Sun L MedComm (2020). 2025; 6(3):e70101.
PMID: 40060194 PMC: 11885892. DOI: 10.1002/mco2.70101.
The emerging role of neutrophil extracellular traps in ulcerative colitis.
Long D, Mao C, Xu Y, Zhu Y Front Immunol. 2024; 15:1425251.
PMID: 39170617 PMC: 11335521. DOI: 10.3389/fimmu.2024.1425251.
Hemorrhage in acute promyelocytic leukemia-fibrinolysis in focus.
Sabljic N, Thachil J, Pantic N, Mitrovic M Res Pract Thromb Haemost. 2024; 8(5):102499.
PMID: 39130779 PMC: 11314889. DOI: 10.1016/j.rpth.2024.102499.
Thrombosis in Myeloid Malignancies: From CHIP to AML.
Borsellino B, Bravo-Perez C, Visconte V, Guarnera L Cardiovasc Hematol Disord Drug Targets. 2024; 24(1):2-12.
PMID: 38879768 DOI: 10.2174/011871529X307253240530060107.
Deregulation of New Cell Death Mechanisms in Leukemia.
Favale G, Donnarumma F, Capone V, Della Torre L, Beato A, Carannante D Cancers (Basel). 2024; 16(9).
PMID: 38730609 PMC: 11083363. DOI: 10.3390/cancers16091657.